143 related articles for article (PubMed ID: 16497664)
1. Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells.
Loriot A; De Plaen E; Boon T; De Smet C
J Biol Chem; 2006 Apr; 281(15):10118-26. PubMed ID: 16497664
[TBL] [Abstract][Full Text] [Related]
2. Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cells.
De Smet C; Loriot A; Boon T
Mol Cell Biol; 2004 Jun; 24(11):4781-90. PubMed ID: 15143172
[TBL] [Abstract][Full Text] [Related]
3. Mouse embryonic stem cells induce targeted DNA demethylation within human MAGE-A1 transgenes.
Loriot A; Sterpin C; De Backer O; De Smet C
Epigenetics; 2008; 3(1):38-42. PubMed ID: 18094622
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b.
James SR; Link PA; Karpf AR
Oncogene; 2006 Nov; 25(52):6975-85. PubMed ID: 16715135
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter.
De Smet C; Lurquin C; Lethé B; Martelange V; Boon T
Mol Cell Biol; 1999 Nov; 19(11):7327-35. PubMed ID: 10523621
[TBL] [Abstract][Full Text] [Related]
6. Expression of MAGE-A1 mRNA is associated with gene hypomethylation in hepatocarcinoma cell lines.
Xiao J; Chen HS; Fei R; Cong X; Wang LP; Wang Y; Jiang D; Wei L; Wang Y
J Gastroenterol; 2005 Jul; 40(7):716-21. PubMed ID: 16082588
[TBL] [Abstract][Full Text] [Related]
7. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.
Vatolin S; Abdullaev Z; Pack SD; Flanagan PT; Custer M; Loukinov DI; Pugacheva E; Hong JA; Morse H; Schrump DS; Risinger JI; Barrett JC; Lobanenkov VV
Cancer Res; 2005 Sep; 65(17):7751-62. PubMed ID: 16140943
[TBL] [Abstract][Full Text] [Related]
8. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells.
Wischnewski F; Pantel K; Schwarzenbach H
Mol Cancer Res; 2006 May; 4(5):339-49. PubMed ID: 16687489
[TBL] [Abstract][Full Text] [Related]
9. Demethylation of MAGE promoters during gastric cancer progression.
Honda T; Tamura G; Waki T; Kawata S; Terashima M; Nishizuka S; Motoyama T
Br J Cancer; 2004 Feb; 90(4):838-43. PubMed ID: 14970862
[TBL] [Abstract][Full Text] [Related]
10. Transcription of the MAGE-1 gene and the methylation status of its Ets binding promoter elements: a quantitative analysis in melanoma cell lines using a real-time polymerase chain reaction technique.
Janssen BL; van de Locht LT; Fourkour A; de Smet C; Mensink EJ; van Muijen GN; de Vries TJ
Melanoma Res; 1999 Jun; 9(3):213-22. PubMed ID: 10465576
[TBL] [Abstract][Full Text] [Related]
11. Role of DNA methyltransferases in regulation of human ribosomal RNA gene transcription.
Majumder S; Ghoshal K; Datta J; Smith DS; Bai S; Jacob ST
J Biol Chem; 2006 Aug; 281(31):22062-22072a. PubMed ID: 16735507
[TBL] [Abstract][Full Text] [Related]
12. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721.
Fan H; Zhao Z; Quan Y; Xu J; Zhang J; Xie W
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):952-61. PubMed ID: 18049164
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.
Kim KH; Choi JS; Kim IJ; Ku JL; Park JG
World J Gastroenterol; 2006 Sep; 12(35):5651-7. PubMed ID: 17007017
[TBL] [Abstract][Full Text] [Related]
14. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
15. MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.
Grau E; Oltra S; Martínez F; Orellana C; Cañete A; Fernández JM; Hernández-Martí M; Castel V
J Cancer Res Clin Oncol; 2009 Apr; 135(4):523-31. PubMed ID: 18820946
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of methylation of MAGE-A1 and-A3 promoters and expression of DNA methyltransferase in patients with laryngeal squamous cell carcinoma.
Liu S; Zhao Y; Xu Y; Sang M; Zhao R; Gu L; Shan B
Am J Otolaryngol; 2020; 41(1):102318. PubMed ID: 31732299
[TBL] [Abstract][Full Text] [Related]
17. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.
Milutinovic S; Brown SE; Zhuang Q; Szyf M
J Biol Chem; 2004 Jul; 279(27):27915-27. PubMed ID: 15087453
[TBL] [Abstract][Full Text] [Related]
18. Expression of BORIS in melanoma: lack of association with MAGE-A1 activation.
Kholmanskikh O; Loriot A; Brasseur F; De Plaen E; De Smet C
Int J Cancer; 2008 Feb; 122(4):777-84. PubMed ID: 17957795
[TBL] [Abstract][Full Text] [Related]
19. Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer.
Suzuki T; Yoshida K; Wada Y; Hamai Y; Sentani K; Oue N; Yasui W
Oncol Rep; 2007 Aug; 18(2):329-36. PubMed ID: 17611652
[TBL] [Abstract][Full Text] [Related]
20. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
De Smet C; De Backer O; Faraoni I; Lurquin C; Brasseur F; Boon T
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7149-53. PubMed ID: 8692960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
